Persano M, Rimini M, Tada T, Suda G, et al. Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index. Anticancer Res 2023;43:1599-1610.
PMID: 36974779